Mastodawn

sabamirza May 15

OBSN.SW stock collapses dramatically as biotech clinical trial challenges pressure investor confidence severely.

#OBSNSW #BiotechStocks #ClinicalTrials #StockMarket

https://meyka.com/blog/obseva-sa-obsnsw-crashes-769-as-biotech-faces-clinical-trial-headwinds-1505/

ObsEva S.A. (OBSN.SW) Crashes 76.9% as Biotech Faces Clinical Trial Headwinds | Meyka

OBSN.SW stock plummets 76.9% to CHF 0.0012. ObsEva S.A. biotech faces clinical trial challenges in reproductive health pipeline.